Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferran Algaba

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Archives of Pathology & Laboratory Medicine|June 27, 2020
The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate CancerJonathan I Epstein, Mahul B Amin, Samson W Fine, et al.
Urologic Oncology|September 19, 2020
Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician surveySamson W Fine, Kiril Trpkov, Mahul B Amin, et al.
Urologic Oncology|November 10, 2019
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?Anouk E Hentschel, Bas W G van Rhijn, Johannes Bründl, et al.
European Urology|February 25, 2023
Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488]Richard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
European Urology|January 9, 2021
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines PanelRichard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
European Urology Focus|May 16, 2022
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer SpectrumIrene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
International Urology and Nephrology|November 19, 2023
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?Irene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
European Urology Oncology|January 20, 2023
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive SpectrumIrene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
European Urology|January 15, 2008
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part IISusanne Krege, Jörg Beyer, Rainer Souchon, et al.
European Urology|January 15, 2008
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part ISusanne Krege, Jörg Beyer, Rainer Souchon, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Archives of Pathology & Laboratory Medicine|June 27, 2020
The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate CancerJonathan I Epstein, Mahul B Amin, Samson W Fine, et al.
Urologic Oncology|September 19, 2020
Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician surveySamson W Fine, Kiril Trpkov, Mahul B Amin, et al.
Urologic Oncology|November 10, 2019
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?Anouk E Hentschel, Bas W G van Rhijn, Johannes Bründl, et al.
European Urology|February 25, 2023
Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488]Richard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
European Urology|January 9, 2021
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines PanelRichard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
European Urology Focus|May 16, 2022
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer SpectrumIrene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
International Urology and Nephrology|November 19, 2023
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?Irene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
European Urology Oncology|January 20, 2023
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive SpectrumIrene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
European Urology|January 15, 2008
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part IISusanne Krege, Jörg Beyer, Rainer Souchon, et al.
European Urology|January 15, 2008
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part ISusanne Krege, Jörg Beyer, Rainer Souchon, et al.
Pageof 14